Cardiac Output Monitoring Devices Market Analysis

  • Report ID: 4217
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Cardiac Output Monitoring Devices Market Segmentation:

Type Segment Analysis

The invasive segment will hold a market share of 58% over the projected time frame, attributed to the increasing count of cardiac implant surgeries across the globe. In addition to this, the growing popularity of minimally invasive techniques involving arterial and venous lines is also anticipated to augment segment growth. For instance, every year, in the United States, nearly 400,000 coronary artery bypass grafting (CABG) surgeries are performed.

End-user Segment Analysis

The hospital segment is expected to garner a significant share, ascribed to the upsurge in the count of hospitals, followed by the escalating number of patient visits to be diagnosed in hospitals worldwide. For instance, there were over 8,359 hospitals in Japan as of 2020. Whereas Korea had about 4,110 hospitals. Moreover, the availability of favorable medical reimbursement, and surge in the cardiac implant procedures throughout the world are also anticipated to further create numerous opportunities for the growth of the segment.

Our in-depth analysis of the global market includes the following segments:

              By Product

  • Consumables & Accessories
  • Devices

              By Type

  • Invasive
  • Non-Invasive

             By Technology

  • Pulmonary Artery Catheter
  • Lithium Dilution Technique
  • Others

              By End-User

  • Hospitals
  • Ambulatory Surgical Centers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of cardiac output monitoring devices is estimated at USD 1.46 billion.

The global cardiac output monitoring devices market size was around USD 1.4 billion in 2025 and is likely to expand at a CAGR of more than 4.5%, surpassing USD 2.17 billion revenue by 2035.

North America cardiac output monitoring devices market is predicted to capture 40% share by 2035, driven by increasing frequency of heart diseases, coronary artery disease, and rising healthcare expenditure.

Key players in the market include ICU Medical, Inc., Schwarzer Cardiotek GmbH, Edwards Lifesciences Corporation, Baxter International, Inc., Deltex Medical plc, CNSystems Medizintechnik GmbH, Abiomed, Inc., Boston Scientific Corporation (BSC), BioTelemetry, Inc., Masimo Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos